BULLETIN OF STOMATOLOGY AND MAXILLOFACIAL SURGERY

1. Manuscript Submission
Manuscripts must be submitted electronically through the journal’s official manuscript submission system.
The journal accepts manuscripts prepared in Microsoft Word format (.doc or .docx).
By submitting a manuscript, the corresponding author confirms that:
Simultaneous submission of the same manuscript to more than one journal is not permitted.
2. Types of Manuscripts
JBSMFS considers the following categories of manuscripts:
Original Research Articles
Reports of original clinical, experimental, laboratory, epidemiological, observational, and other scientific investigations.
Recommended maximum length: 6,000 words, excluding references, tables, and figure legends.
Review Articles
Comprehensive and critical evaluations of current scientific evidence in dentistry, oral medicine, and maxillofacial surgery. Systematic reviews, meta-analyses, scoping reviews, and narrative reviews are considered.
Recommended maximum length: 8,000 words, excluding references, tables, and figure legends.
Systematic reviews and meta-analyses should follow the relevant PRISMA reporting guidelines.
Case Reports and Case Series
Reports describing clinically significant, unusual, or educational cases that provide relevant diagnostic, therapeutic, or scientific information.
Recommended maximum length: 4,000 words, excluding references and figure legends.
Case reports should follow the CARE reporting guidelines whenever applicable.
Short Communications and Clinical Reports
Brief reports presenting relevant preliminary findings, innovative clinical observations, or methodological developments.
The suitability and length of these submissions will be determined by the editorial office.
3. Manuscript Preparation and General Formatting
Manuscripts should be prepared in a clear, concise, and scientifically appropriate academic style.
The following formatting requirements should be followed:
The manuscript should be organized into clearly identified sections.
4. Title Page
The title page should include:
The title should be informative, concise, and accurately reflect the study design and principal subject.
Abbreviations should generally be avoided in the title.
For randomized controlled trials, systematic reviews, and meta-analyses, the study design should be identified in the title whenever appropriate.
5. Abstract and Keywords
All scholarly articles must include an accurate English-language abstract.
For manuscripts submitted in Armenian or Russian, the corresponding abstract in the original language may also be included.
The abstract should not exceed 300 words.
For original research articles, the abstract should be structured using the following headings:
For review articles, the abstract should briefly describe the background, objective, methods of literature identification and selection, principal findings, and conclusion.
For case reports, the abstract should summarize the clinical background, case presentation, management, outcome, and clinical significance.
Clinical trial registration information should be included in the abstract whenever applicable.
Authors should provide 4–8 keywords, separated by semicolons. Keywords should reflect the main concepts of the manuscript. Where possible, authors are encouraged to use terms from the Medical Subject Headings (MeSH) vocabulary.
6. Main Text Structure
6.1. Introduction
The Introduction should provide the scientific background and rationale for the study.
Authors should:
The Introduction should be focused and should not contain an extensive review of unrelated literature.
6.2. Materials and Methods
The Materials and Methods section should provide sufficient detail to allow other researchers to understand and, where appropriate, reproduce the study.
Authors should clearly describe:
For clinical studies, authors should provide sufficient information about treatment allocation, randomization, blinding, follow-up, and participant withdrawals.
The number of participants initially enrolled, excluded, lost to follow-up, and included in the final analysis should be reported where applicable.
Statistical analyses should be described sufficiently to allow readers to evaluate the reliability of the findings. Authors are encouraged to report effect sizes, confidence intervals, and exact P values where appropriate, rather than relying exclusively on statistical significance.
6.3. Results
The Results section should present the findings clearly and objectively.
All relevant positive and negative findings should be reported.
Results should be organized logically and may be divided into subsections with appropriate headings.
Tables and figures should be used to clarify the findings without unnecessary duplication of information.
Numerical results should be presented accurately, with appropriate statistical indicators.
6.4. Discussion
The Discussion should interpret the principal findings in relation to the existing scientific literature.
Authors should address:
The Discussion should not simply repeat the Results section.
6.5. Conclusion
The Conclusion should provide a concise interpretation of the main findings in relation to the study objectives.
It should reflect the scientific contribution and potential clinical relevance of the research without making claims that are not supported by the presented data.
7. References
JBSMFS follows the Vancouver reference style.
References should be numbered consecutively in the order in which they first appear in the manuscript.
In-text citations should be indicated using Arabic numerals in square brackets.
Authors are responsible for ensuring that all references are accurate, complete, and directly relevant to the manuscript.
Where available, DOI information should be provided.
Authors are encouraged to cite original research articles and authoritative sources from peer-reviewed scientific journals.
Reference details, including author names, article titles, journal titles, publication years, volume numbers, issue numbers, page ranges, and DOI identifiers, must be checked carefully before submission.
References should be presented in Roman script. When citing publications originally published in non-Latin scripts, authors should provide transliterated bibliographic information and, where appropriate, indicate the original language.
8. Tables, Figures, and Illustrations
Tables and figures should be numbered consecutively according to their first appearance in the text.
Each table and figure must have a clear and informative title or legend.
Authors should:
Preferred formats include TIFF, JPEG, PNG, and EPS, depending on the type of image.
Figures reproduced or adapted from previously published sources require appropriate permission and acknowledgement.
9. Authorship and Author Contributions
Authorship should be based on substantial intellectual and scientific contributions to the research.
JBSMFS encourages authors to follow the authorship recommendations of the International Committee of Medical Journal Editors (ICMJE).
All listed authors should meet the following criteria:
All individuals who meet the authorship criteria should be included as authors.
Individuals who contributed to the work but do not meet the authorship criteria should be acknowledged appropriately, with their permission.
Honorary, guest, and ghost authorship are not acceptable.
A statement describing the specific contributions of each author should be included using the CRediT (Contributor Roles Taxonomy) framework whenever applicable.
The corresponding author is responsible for ensuring that all authors have approved the final manuscript and agreed to its submission.
Changes to the author list after submission require written agreement from all affected authors and approval by the Editor-in-Chief.
10. Funding Statement
All sources of financial support must be disclosed.
Authors should identify:
If the research received no external financial support, authors should include the statement:
“This research received no external funding.”
11. Conflict of Interest
All authors must disclose any financial, personal, professional, or institutional relationships that could influence, or be perceived to influence, the research or its interpretation.
Potential conflicts include employment, consultancy, honoraria, grants, stock ownership, patents, and relationships with manufacturers of products or devices discussed in the manuscript.
If no competing interests exist, authors should include the following statement:
“The authors declare no conflicts of interest.”
All disclosures will be considered during editorial evaluation.
12. Data Availability Statement
Authors are encouraged to provide a Data Availability Statement indicating whether the data supporting the findings are available and, where applicable, how they can be accessed.
The statement should specify whether the data are:
Authors must ensure that data sharing does not compromise participant confidentiality or violate ethical approval conditions.
13. Reporting Guidelines
Authors are encouraged to follow internationally recognized reporting guidelines appropriate to their study design.
Examples include:
Relevant reporting checklists and flow diagrams should be submitted as supplementary files when applicable.
14. Use of Artificial Intelligence Tools
Authors must disclose the use of generative artificial intelligence (AI) tools or AI-assisted technologies in the preparation of the manuscript when such tools have contributed to the development of the submitted content.
The disclosure should identify the tool and describe its role.
AI tools cannot be listed as authors because they cannot assume responsibility for the accuracy, originality, and integrity of the work.
Authors remain fully responsible for all submitted content, including the verification of references, data, statistical analyses, and statements generated or assisted by AI tools.
The use of AI tools for language editing, grammar correction, or improvement of readability should be disclosed when it constitutes a substantive contribution to manuscript preparation.
AI tools must not be used to fabricate, manipulate, or falsify research data, images, or scientific results.
15. Acknowledgments
Individuals who contributed to the research but do not meet the criteria for authorship may be acknowledged.
Their contributions should be described clearly, and their permission to be acknowledged should be obtained before submission.
Funding information should be reported separately in the Funding Statement.
16. Article Processing Charges (APC)
JBSMFS is a self-funded, open access journal. Article Processing Charges support editorial management, peer-review administration, DOI registration, typesetting, online publication, hosting, and digital archiving.
The current APC structure is as follows:
APCs are requested only after a manuscript has been formally accepted.
An official invoice is issued together with the galley proof of the accepted article.
Publication proceeds after confirmation of payment.
Payment of an APC does not guarantee acceptance and has no influence on peer-review outcomes or editorial decisions.
Partial or full waivers may be considered in exceptional circumstances, including limited institutional funding, early-career researchers, students, or invited manuscripts.
Waiver requests should be submitted before or during peer review and are evaluated independently of editorial decisions.
17. Editorial and Publication Timeline
The journal aims to maintain an efficient and transparent editorial process.
The approximate processing times are:
These periods are indicative and may vary depending on reviewer availability, manuscript complexity, and the time required for author revisions.
18. Final Submission Checklist
Before submitting a manuscript, authors should ensure that: